Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1

Yu Ikezono(Kurume University), Takuji Torimura(Omuta hospital), Hironori Koga(Kurume University), Atsutaka Masuda(Kurume University), Hirohisa Yano(Kurume University), Jun Akiba(Kurume University), Tõru Nakamura, Hideki Iwamoto, Osamu Tsuruta(Kurume University), Takahiko Sakaue(Kurume University), Takafumi Yoshida(Kurume University), Mitsuhiko Abe(Kurume University), Fumitaka Wada(Kurume University)
Molecular Cancer Research
February 8, 2017
10.1158/1541-7786.mcr-16-0285
Cited by 39

Related Papers

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600